These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26261062)

  • 41. Assessment of healthcare professionals' knowledge, attitudes, and perceived challenges of clinical pharmacogenetic testing in Egypt.
    Nagy M; Lynch M; Kamal S; Mohamed S; Hadad A; Abouelnaga S; Aquilante CL
    Per Med; 2020 Jul; 17(4):251-260. PubMed ID: 32589096
    [No Abstract]   [Full Text] [Related]  

  • 42. Clinical Review of the Pharmacogenomics of Direct Oral Anticoagulants.
    Tseng AS; Patel RD; Quist HE; Kekic A; Maddux JT; Grilli CB; Shamoun FE
    Cardiovasc Drugs Ther; 2018 Feb; 32(1):121-126. PubMed ID: 29435777
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact and applicability of pharmacogenomics in rheumatology: an integrated analysis.
    Reid P; Danahey K; Lopez Velazquez M; Ratain MJ; O'Donnell PH
    Clin Exp Rheumatol; 2021; 39(6):1385-1393. PubMed ID: 33506753
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toward Personalized Medicine Implementation: Survey of Military Medicine Providers in the Area of Pharmacogenomics.
    DeLuca J; Selig D; Poon L; Livezey J; Oliver T; Barrett J; Turner C; Hellwig L
    Mil Med; 2020 Mar; 185(3-4):336-340. PubMed ID: 31786583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patient perspectives following pharmacogenomics results disclosure in an integrated health system.
    Lemke AA; Hulick PJ; Wake DT; Wang C; Sereika AW; Yu KD; Glaser NS; Dunnenberger HM
    Pharmacogenomics; 2018 Mar; 19(4):321-331. PubMed ID: 29469671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Perceptions of students in health and molecular life sciences regarding pharmacogenomics and personalized medicine.
    Mahmutovic L; Akcesme B; Durakovic C; Akcesme FB; Maric A; Adilovic M; Hamad N; Wjst M; Feeney O; Semiz S
    Hum Genomics; 2018 Nov; 12(1):50. PubMed ID: 30424805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy.
    Empey PE; Stevenson JM; Tuteja S; Weitzel KW; Angiolillo DJ; Beitelshees AL; Coons JC; Duarte JD; Franchi F; Jeng LJB; Johnson JA; Kreutz RP; Limdi NA; Maloney KA; Owusu Obeng A; Peterson JF; Petry N; Pratt VM; Rollini F; Scott SA; Skaar TC; Vesely MR; Stouffer GA; Wilke RA; Cavallari LH; Lee CR;
    Clin Pharmacol Ther; 2018 Oct; 104(4):664-674. PubMed ID: 29280137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patient-provider communications about pharmacogenomic results increase patient recall of medication changes.
    Borden BA; Lee SM; Danahey K; Galecki P; Patrick-Miller L; Siegler M; Sorrentino MJ; Sacro Y; Davis AM; Rubin DT; Lipstreuer K; Polonsky TS; Nanda R; Harper WR; Koyner JL; Burnet DL; Stadler WM; Kavitt RT; Meltzer DO; Ratain MJ; O'Donnell PH
    Pharmacogenomics J; 2019 Dec; 19(6):528-537. PubMed ID: 30713337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacogenomics: Prescribing Precisely.
    Wake DT; Ilbawi N; Dunnenberger HM; Hulick PJ
    Med Clin North Am; 2019 Nov; 103(6):977-990. PubMed ID: 31582008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Paradoxical psoriasiform reactions to anti-TNFα drugs are associated with genetic polymorphisms in patients with psoriasis.
    Cabaleiro T; Prieto-Pérez R; Navarro R; Solano G; Román M; Ochoa D; Abad-Santos F; Daudén E
    Pharmacogenomics J; 2016 Aug; 16(4):336-40. PubMed ID: 26194362
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prenatal pharmacogenomics: a promising area for research.
    Dorfman EH; Cheng EY; Hebert MF; Thummel KE; Burke W
    Pharmacogenomics J; 2016 Aug; 16(4):303-4. PubMed ID: 27168097
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Knowledge, attitude, future expectations and perceived barriers of medical students and physicians regarding pharmacogenomics in Jordan.
    Alzoubi A; Kanaan H; Alhazaimeh D; Gharaibeh S; Mukattash TL; Kheirallah K
    Int J Clin Pract; 2021 Jan; 75(1):e13658. PubMed ID: 32772487
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.
    Swen JJ; van der Wouden CH; Manson LE; Abdullah-Koolmees H; Blagec K; Blagus T; Böhringer S; Cambon-Thomsen A; Cecchin E; Cheung KC; Deneer VH; Dupui M; Ingelman-Sundberg M; Jonsson S; Joefield-Roka C; Just KS; Karlsson MO; Konta L; Koopmann R; Kriek M; Lehr T; Mitropoulou C; Rial-Sebbag E; Rollinson V; Roncato R; Samwald M; Schaeffeler E; Skokou M; Schwab M; Steinberger D; Stingl JC; Tremmel R; Turner RM; van Rhenen MH; Dávila Fajardo CL; Dolžan V; Patrinos GP; Pirmohamed M; Sunder-Plassmann G; Toffoli G; Guchelaar HJ;
    Lancet; 2023 Feb; 401(10374):347-356. PubMed ID: 36739136
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acceptability, Feasibility, and Utility of Integrating Pharmacogenetic Testing into a Child Psychiatry Clinic.
    Claudio-Campos K; Padrón A; Jerkins G; Nainaparampil J; Nelson R; Martin A; Wiisanen K; Smith DM; Strekalova Y; Marsiske M; Cicali EJ; Cavallari LH; Mathews CA
    Clin Transl Sci; 2021 Mar; 14(2):589-598. PubMed ID: 33166056
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing.
    Reizine NM; Danahey K; Truong TM; George D; House LK; Karrison TG; van Wijk XMR; Yeo KJ; Ratain MJ; O'Donnell PH
    Cancer; 2022 Apr; 128(8):1649-1657. PubMed ID: 35090043
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Experience and expectations of pharmacogenetic tests in France.
    Verdez S; Bardou M; Duffourd Y; Luu M; Thauvin-Robinet C; Faivre L; Picard N
    Therapie; 2024; 79(3):341-349. PubMed ID: 37516659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychiatric pharmacists' perception on the use of pharmacogenomic testing in the mental health population.
    Shishko I; Almeida K; Silvia RJ; Tataronis GR
    Pharmacogenomics; 2015; 16(9):949-58. PubMed ID: 26100610
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients.
    Frigon MP; Blackburn MÈ; Dubois-Bouchard C; Gagnon AL; Tardif S; Tremblay K
    Pharmacogenomics; 2019 Jun; 20(8):589-598. PubMed ID: 31190623
    [No Abstract]   [Full Text] [Related]  

  • 59. Implementation of pharmacogenomics into inpatient general medicine.
    Chen T; O'Donnell PH; Middlestadt M; Ruhnke GW; Danahey K; van Wijk XMR; Choksi A; Knoebel R; Hartman S; Yeo KJ; Friedman PN; Ratain MJ; Nutescu EA; O'Leary KJ; Perera MA; Meltzer DO
    Pharmacogenet Genomics; 2023 Feb; 33(2):19-23. PubMed ID: 36729768
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of clinical impact of pharmacogenomics knowledge involved in CPIC guidelines on Chinese pediatric patients.
    Qin W; Du Z; Xiao J; Duan H; Shu Q; Li H
    Pharmacogenomics; 2020 Feb; 21(3):209-219. PubMed ID: 31967514
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.